Literature DB >> 28325479

The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice.

Adam P Chambers1, Joyce E Sorrell2, April Haller2, Karen Roelofs3, Chelsea R Hutch3, Ki-Suk Kim3, Ruth Gutierrez-Aguilar4, Bailing Li2, Daniel J Drucker5, David A D'Alessio6, Randy J Seeley3, Darleen A Sandoval7.   

Abstract

Glucagon-like peptide 1 (GLP-1) is necessary for normal gluco-regulation, and it has been widely presumed that this function reflects the actions of GLP-1 released from enteroendocrine L cells. To test the relative importance of intestinal versus pancreatic sources of GLP-1 for physiological regulation of glucose, we administered a GLP-1R antagonist, exendin-[9-39] (Ex9), to mice with tissue-specific reactivation of the preproglucagon gene (Gcg). Ex9 impaired glucose tolerance in wild-type mice but had no impact on Gcg-null or GLP-1R KO mice, suggesting that Ex9 is a true and specific GLP-1R antagonist. Unexpectedly, Ex-9 had no effect on blood glucose in mice with restoration of intestinal Gcg. In contrast, pancreatic reactivation of Gcg fully restored the effect of Ex9 to impair both oral and i.p. glucose tolerance. These findings suggest an alternative model whereby islet GLP-1 also plays an important role in regulating glucose homeostasis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GLP-1; glucose homeostasis; incretin

Mesh:

Substances:

Year:  2017        PMID: 28325479      PMCID: PMC5385998          DOI: 10.1016/j.cmet.2017.02.008

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  28 in total

Review 1.  Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.

Authors:  Darleen A Sandoval; David A D'Alessio
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

Authors:  J Schirra; K Sturm; P Leicht; R Arnold; B Göke; M Katschinski
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

3.  Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

Authors:  L Hansen; C F Deacon; C Orskov; J J Holst
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

4.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

Authors:  L A Scrocchi; T J Brown; N MaClusky; P L Brubaker; A B Auerbach; A L Joyner; D J Drucker
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

5.  GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats.

Authors:  Tohru Hira; Taisuke Mochida; Kyoko Miyashita; Hiroshi Hara
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-06       Impact factor: 4.052

6.  Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration.

Authors:  German Kilimnik; Abraham Kim; Donald F Steiner; Theodore C Friedman; Manami Hara
Journal:  Islets       Date:  2010 May-Jun       Impact factor: 2.694

7.  Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.

Authors:  Safina Ali; Benjamin J Lamont; Maureen J Charron; Daniel J Drucker
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

8.  Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.

Authors:  J Schirra; M Nicolaus; R Roggel; M Katschinski; M Storr; H J Woerle; B Göke
Journal:  Gut       Date:  2005-06-28       Impact factor: 23.059

9.  Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.

Authors:  R W Gelling; X Q Du; D S Dichmann; J Romer; H Huang; L Cui; S Obici; B Tang; J J Holst; C Fledelius; P B Johansen; L Rossetti; L A Jelicks; P Serup; E Nishimura; M J Charron
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

Review 10.  GLP-1 effects on islets: hormonal, neuronal, or paracrine?

Authors:  Marc Y Donath; Rémy Burcelin
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

View more
  78 in total

1.  Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis.

Authors:  Tito Borner; Jayme L Workinger; Ian C Tinsley; Samantha M Fortin; Lauren M Stein; Oleg G Chepurny; George G Holz; Aleksandra J Wierzba; Dorota Gryko; Ebba Nexø; Evan D Shaulson; Ankur Bamezai; Valentina A Rodriguez Da Silva; Bart C De Jonghe; Matthew R Hayes; Robert P Doyle
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy.

Authors:  Ki-Suk Kim; Chelsea R Hutch; Landon Wood; Irwin J Magrisso; Randy J Seeley; Darleen A Sandoval
Journal:  JCI Insight       Date:  2019-10-17

4.  Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.

Authors:  Oleg G Chepurny; Minos-Timotheos Matsoukas; George Liapakis; Colin A Leech; Brandon T Milliken; Robert P Doyle; George G Holz
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

5.  Sleeve gastrectomy rapidly enhances islet function independently of body weight.

Authors:  Jonathan D Douros; Jingjing Niu; Sophia Sdao; Trillian Gregg; Kelsey Fisher-Wellman; Manish Bharadwaj; Anthony Molina; Ramamani Arumugam; MacKenzie Martin; Enrico Petretto; Matthew J Merrins; Mark A Herman; Jenny Tong; Jonathan Campbell; David D'Alessio
Journal:  JCI Insight       Date:  2019-03-21

Review 6.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

7.  The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition.

Authors:  Megan E Capozzi; Reilly W Coch; Jepchumba Koech; Inna I Astapova; Jacob B Wait; Sara E Encisco; Jonathan D Douros; Kimberly El; Brian Finan; Kyle W Sloop; Mark A Herman; David A D'Alessio; Jonathan E Campbell
Journal:  Diabetes       Date:  2020-01-31       Impact factor: 9.461

8.  A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodents.

Authors:  Elizabeth G Mietlicki-Baase; Claudia G Liberini; Jayme L Workinger; Ron L Bonaccorso; Tito Borner; David J Reiner; Kieran Koch-Laskowski; Lauren E McGrath; Rinzin Lhamo; Lauren M Stein; Bart C De Jonghe; George G Holz; Christian L Roth; Robert P Doyle; Matthew R Hayes
Journal:  Diabetes Obes Metab       Date:  2018-02-20       Impact factor: 6.577

9.  Updating the Role of α-Cell Preproglucagon Products on GLP-1 Receptor-Mediated Insulin Secretion.

Authors:  Darleen Sandoval
Journal:  Diabetes       Date:  2020-11       Impact factor: 9.461

10.  Engineering Mammalian Cells to Control Glucose Homeostasis.

Authors:  Jiawei Shao; Xinyuan Qiu; Mingqi Xie
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.